Infant outcomes among pregnant women who used oseltamivir for treatment of influenza during the H1N1 epidemic

Source: American Journal of Obstetrics and Gynecology Area: News According to research reported early online in the American Journal of Obstetrics and Gynecology, use of oseltamivir to treat or prevent H1N1 influenza during pregnancy does not appear to increase the risk of early birth, poor foetal growth or a low Apgar score at birth.   The researchers note that only a few studies have examined the association between maternal use of oseltamivir and pregnancy outcomes. Although the benefit of treatment of pregnant women with antivirals is presumed to outweigh its risks, the limited information available is challenging for both healthcare providers and pregnant women. The aim of their study was to assess the effect of maternal oseltamivir use for treatment or prevention of influenza during the 2009 HINI influenza pandemic on infant outcomes.   The Canadian population-based retrospective cohort study included all women in Ontario who gave birth to a singleton infant weighing ?500g at ?20 weeks of gestation from November 2009 ...
Source: NeLM - News - Category: Drugs & Pharmacology Source Type: news